# De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

> **NCT05808192** · — · COMPLETED · sponsor: **University of Rome Tor Vergata** · enrollment: 92 (actual)

## Conditions studied

- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS

## Interventions

- **DRUG:** Immunosuppressive

## Key facts

- **NCT ID:** NCT05808192
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05808192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05808192, "De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05808192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*